| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | -0.0077 | 0.8 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | -0.0069 | 0.8 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.8 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | epigallocatechin-3-monogallate | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.007 | 0.8 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.008 | 0.8 |